What is the fate of artificial urinary sphincters among men undergoing repetitive bladder cancer treatment?

S Mitchell HeinerBoyd R ViersMarcelino E RiveraBrian J LinderDaniel S Elliott

Published in: Investigative and clinical urology (2017)

Bladder cancer surveillance and treatment with an AUS device in place appears to confer minimal additional risk to AUS survival. Careful attention should be given to device deactivation and use of the smallest caliber instruments available to minimize the risk of iatrogenic urethral erosion.

Keyphrases

public health
spinal cord injury
working memory
high frequency
middle aged
combination therapy
free survival